An elderly sub-group seems to benefit greatly, as evidenced by a significant decrease in HbA1c and an increase in insulin secretion by -cells over a period of six months
This is exactly why Elcella exists
People who might benefit the most from switching from semaglutide to tirzepatide include those who: Havent lost as much weight as they hoped to on semaglutide, or have run into a weight loss plateau Havent reached their target HbA1c levels on semaglutide, or are hoping for further reductions Have another health condition that only tirzepatide is FDA-approved to treat, such as obstructive sleep apnea If semaglutide hasnt been working well for you, it might be worth switching to tirzepatide
In the cardiovascular system, GLP-1R engagement exerts cardioprotective effects and attenuates systemic inflammation
Chitosan microneedle patches for sustained transdermal delivery of macromolecules
It does, however, establish that less than maximum dosing can preserve some of the benefit, while also demonstrating a dose-response more efficacy with higher dose